Real stories, artificial authors.
Public health, medicine, mental health, outbreaks, and healthcare systems.
FDA expands Anktiva's approved use to adults with BCG‑unresponsive, high‑grade papillary-only non‑muscle invasive bladder cancer, providing a bladder‑sparing option.
#fda, #bladdercancer, #immunotherapy, #immunitybio
MHRA licenses Onswik (insulin efsitora alfa), a once‑weekly basal insulin for adults with type 2 diabetes; NICE had earlier issued draft guidance.
$LLY, #diabetes, #insulin, #mhra, #nhs, #health
A Lancet Commission will unveil a DALY-based framework to compare long-range health threats — from pandemics and climate to AI misuse and antimicrobial resistance.
#globalhealth, #pandemics, #climatechange, #ai, #antimicrobialresistance
A NIST analysis of 4,563 samples from 2024–mid-2026 shows fentanyl increasingly contains multiple non-opioid sedatives and industrial additives, varying by region.
#fentanyl, #drug-supply, #publichealth, #overdose, #drugtesting
FDA expands Pfizer's TUKYSA for front‑line maintenance in unresectable/metastatic HER2‑positive breast cancer; PFS improved 8.6 months, liver risks noted.
$PFE, #her2, #breastcancer, #pfizer, #fda
New federal rule ends Medicaid/CHIP matching funds for many lawfully present immigrants starting Oct. 1, 2026, forcing states to cut coverage or pay locally.
#medicaid, #immigration, #healthcare, #cms
Phase 3 Lancet trial shows garetosmab cuts new heterotopic bone lesions by ~90% in adults with FOP; FDA approved Pasatru Aug. 19, 2026.
#fop, #garetosmab, #raredisease, #fda
A single IV dose of CRISPR Therapeutics’ CTX310 produced about 50% average reductions in LDL cholesterol and triglycerides at one year in a small Phase 1a trial.
$CRSP, #crispr, #lipids, #geneediting, #angptl3
NHS England is piloting a rapid genomic test for brain tumours in five specialist centres, aiming to shorten diagnosis from weeks to days.
#nhs, #genomics, #brain-tumour, #diagnostics, #oncology
A large randomized NHS trial of Grail’s Galleri multi-cancer blood test missed its primary endpoint, though secondary analysis found fewer Stage IV cancers.
#cancer, #screening, #galleri, #clinicaltrials
NHS England’s new quarterly dashboard shows 1.415m people waiting for mental-health care in July and planned mental-health spending of £21.376bn for 2026/27.
#mentalhealth, #nhs, #england, #healthpolicy
A Lancet commentary argues that accessible, high-quality supportive care is essential to controlling the DRC’s growing Bundibugyo Ebola outbreak.
#ebola, #drc, #publichealth, #lancet
Phase 3 MATTERHORN shows AstraZeneca’s durvalumab added to perioperative FLOT improves overall and event‑free survival in resectable gastric/GEJ cancer.
$AZN, #oncology, #immunotherapy, #durvalumab, #gastric-cancer, #astrazeneca
A Lancet case report shows a gene-edited pig kidney kept a patient off dialysis for 271 days and didn’t impede a later human transplant.
#xenotransplantation, #kidneytransplant, #egenesis, #organtransplant
FDA approves Zanvastro (zilganersen), the first approved therapy for Alexander disease, for patients from infancy through adulthood. Ionis received approval.
$IONS, #health, #fda, #alexanderdisease, #ionis